Showing results (731-740 of 834) with videos related to
Sort By:
Pageof 84
ACS Chemical Biology|May 1, 2020
mRNA Display Discovery of a Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)Golnaz Kamalinia, Brian J Engel, Anupallavi Srinivasamani, et al.Peptides|March 1, 1984
Vasoactive intestinal peptide in cerebrospinal fluidN S Sharpless, L J Thal, M J Perlow, et al.Journal of Cancer Research and Clinical Oncology|April 28, 2017
Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomesMiriam Rottmann, A Burges, S Mahner, et al.Chest|August 7, 2021
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled TrialRobert P Baughman, Oksana A Shlobin, Rohit Gupta, et al.Gynecologic Oncology|April 28, 2019
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patientsM Pölcher, M Rottmann, S Brugger, et al.The Journal of Biological Chemistry|January 13, 2001
An intrahelical salt bridge within the trigger site stabilizes the GCN4 leucine zipperR A Kammerer, V A Jaravine, S Frank, et al.Epilepsy Research|April 1, 1996
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizuresA Rostock, C Tober, C Rundfeldt, et al.Neurology|October 12, 2005
Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsyJ J Lin, N Salamon, R A Dutton, et al.Neuroendocrinology|March 1, 1989
Presence of prolactin-like immunoreactivity and bioactivity in rat spinal cordN V Emanuele, N Azad, J P Luckey, et al.Human Reproduction (Oxford, England)|November 18, 1997
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist CetrorelixD Gonzalez-Barcena, R B Alvarez, E P Ochoa, et al.Pageof 84